8Stock.Com Real Time Signal Analysis By Industry Sectors

8Stock.Com Real Time Signal Analysis
By Industry Sectors.

RSS Stock Market Analysis With Sector Related News Feed

Free Bursa Malaysia (KLSE) Hot Share Tips, Blogs / Forums, Research & Resources

Bursa Malaysia Free Hot Share Tips, Blogs / Forums, Research & KLSE Resources

INDUSTRY SECTOR Real Time Intraday Signal

US (Nasdaq, NYSE, AMEX) RSS News Feed

Live Link | INSURANCE | RSS News Feed | LTrader

HEALTH CARE, BIOTECHNOLOGY, DRUGS, PHARMACEUTICALS, MEDICAL

Live Link | HEALTH CARE | RSS News Feed | LTrader

Aveo Pharmaceuticals Goes Public at $9, Falls Short of Hoped-For Range - Xconomy

Aveo Pharmaceuticals Goes Public at $9, Falls Short of Hoped-For Range
Xconomy
... lackluster interest in biotech from public investors. Cambridge, MA-based Ironwood Pharmaceuticals (NASDAQ: IRWD) was first out of the gate this year, ...
Aveo raises $81m in initial offeringBoston Globe
Biotech IPO: AVEO Pharma Develops Cancer TherapeuticsSeeking Alpha (blog)

all 29 news articles »

Xoma 4Q profit falls as contract revenue tumbles - The Associated Press

Xoma 4Q profit falls as contract revenue tumbles
The Associated Press
Biotechnology company Xoma Ltd. said Thursday its fourth-quarter profit fell as its contract revenue dipped. Xoma earned $3 million, or a penny per share, ...
XOMA Reports 2009 and Fourth Quarter Financial ResultsCNNMoney.com (press release)

all 122 news articles »

BioSante rallies on study; drug stocks slip - MarketWatch

BioSante rallies on study; drug stocks slip
MarketWatch
The NYSE Arca Pharmaceutical Index (INDEX:DRG) was up nominally at 306.63 while the NYSE Arca Biotechnology Index (INDEX:BTK) eased slightly to rest at ...
BioSante soars on study; drug stocks slipMarketWatch

all 50 news articles »

Abbott agrees to acquire Facet Biotech for USD450m - Trading Markets (press release)

BNET

Abbott agrees to acquire Facet Biotech for USD450m
Trading Markets (press release)
Pharmaceuticals and medical products supplier Abbott Laboratories (NYSE: ABT | Quote | Chart | News | PowerRating) said on Tuesday that has signed a ...
Facet, InterMune lead drug stocks northMarketWatch
Abbott's New AdditionInvestopedia
Facet Biotech Wooed by $722M Acquisition Offer from AbbottBioWorld Online
FOXBusiness -StreetInsider.com (subscription) (blog) -Reuters
all 490 news articles »

Nymox Reports 2009 Financial Results - CNNMoney.com (press release)

Nymox Reports 2009 Financial Results
CNNMoney.com (press release)
Nymox Pharmaceutical Corporation is a biotechnology company engaged in the research and development of therapeutics and diagnostics, with a particular ...

and more »

Nutra Pharma to Exhibit at the 12th IDGA Battlefield Healthcare Summit in ... - MarketWatch (press release)

Nutra Pharma to Exhibit at the 12th IDGA Battlefield Healthcare Summit in ...
MarketWatch (press release)
Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products ...
RxNews Recap for Thursday 03-11-10BioMedReports (subscription) (blog)

all 20 news articles »

Investing in the Biotechnology Industry - Wealth Daily

Investing in the Biotechnology Industry
Wealth Daily
Last week, Astellas Pharma announced a hostile $3.5 billion offer for OSI Pharmaceuticals ( NASDAQ: OSIP) or $52 a share — a 40% premium over the previous ...

Collaboration revenue gives Synta $79.1M profit - Mass High Tech

Collaboration revenue gives Synta $79.1M profit
Mass High Tech
By Mass High Tech staff Despite reporting a fourth quarter loss, Lexington-based biotech Synta Pharmaceuticals Corp. ended 2009 with a net profit of $79.1 ...

and more »

Follow the 'Strong Hands' Into Ironwood Pharmaceuticals (IRWD) - StreetInsider.com (subscription)

Follow the 'Strong Hands' Into Ironwood Pharmaceuticals (IRWD)
StreetInsider.com (subscription)
A number of investment funds have piled into recent biotech IPO Ironwood Pharmaceuticals (Nasdaq: IRWD), as disclosed in 13G filings and other filings over ...

Abraxis BioScience Reports 2009 Fourth Quarter and Full Year Financial Results - MarketWatch (press release)

Abraxis BioScience Reports 2009 Fourth Quarter and Full Year Financial Results
MarketWatch (press release)
LOS ANGELES, Mar 11, 2010 (BUSINESS WIRE) -- Abraxis BioScience, Inc. (NASDAQ:ABII) , a fully integrated biotechnology company, today reported financial ...

and more »

Google News

TECHNOLOGY

World Wide Leader in Football match reviews, critics, reactions, rants